CHARLES RIVER LABORATORIES INTERNATIONAL INC (CRL) is a publicly traded company in the Unknown sector. Across all available filings, 24 corporate insiders have executed 1004 transactions totaling $182.7M, demonstrating a bearish sentiment with -$175.0M in net insider flow. The most recent transaction on Nov 6, 2025 involved a transaction of 2,926 shares valued at $500.0K.
No significant insider buying has been recorded for CRL in the recent period.
No significant insider selling has been recorded for CRL in the recent period.
Based on recent SEC filings, insider sentiment for CRL is bearish with an Insider Alignment Score of 2/100 and a net flow of -$175.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CHARLES RIVER LABORATORIES INTERNATIONAL INC (CRL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 24 insiders are actively trading CRL stock, having executed 1004 transactions in the past 90 days. The most active insider is James C. Foster (Executive), who has made 192 transactions totaling $160.4M.
Get notified when executives and directors at CRL file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 6, 2025 | Gunnar Knell Michael | Executive | Award | 2,926 | $170.88 | $500.0K | |
| Aug 22, 2025 | W. Laplume Joseph | EVP, Corp Strategy & Develop | Sale | 400 | $163.72 | $65.5K | |
| Aug 18, 2025 | W. Laplume Joseph | Executive | Sale | 800 | $157.60 | $126.1K | |
| Aug 7, 2025 | W. Laplume Joseph | Executive | Sale | 400 | $150.04 | $60.0K | |
| Aug 12, 2024 | C. Foster James | Executive | Gift | 2,500 | $N/A | $0 | |
| Aug 8, 2024 | W. Laplume Joseph | Executive | Sale | 1,780 | $199.36 | $354.9K | |
| Aug 1, 2024 | C. Foster James | Executive | Sale | 25,000 | $250.00 | $6.3M | Large10b5-1 |
| Jun 3, 2024 | W. Laplume Joseph | Executive | Gift | 311 | $N/A | $0 | |
| May 31, 2024 | W. Laplume Joseph | Executive | Award | 2,111 | $N/A | $0 | |
| May 31, 2024 | Gunnar Knell Michael | Executive | Award | 648 | $N/A | $0 | |
| May 31, 2024 | Pease Flavia | Executive | Award | 2,159 | $N/A | $0 | |
| May 31, 2024 | Girshick Birgit | Executive | Award | 3,838 | $N/A | $0 | |
| May 31, 2024 | L. Creamer Victoria | Executive | Award | 1,967 | $N/A | $0 | |
| May 31, 2024 | M. Parisotto Shannon | Executive | Award | 1,727 | $N/A | $0 | |
| May 29, 2024 | Girshick Birgit | Executive | Payment | 216 | $214.51 | $46.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 495 | $178.8M | 58.5% |
Payment(F) | 189 | $69.6M | 22.7% |
Exercise(M) | 87 | $51.4M | 16.8% |
Purchase(P) | 7 | $3.8M | 1.3% |
Award(A) | 161 | $2.2M | 0.7% |
Gift(G) | 65 | $0 | 0.0% |
Insider selling pressure at CHARLES RIVER LABORATORIES INTERNATIONAL INC has increased, with 24 insiders executing 1004 transactions across all time. Total sales of $178.8M significantly outpace purchases of $3.8M, resulting in a net outflow of $175.0M. This selling activity appears largely discretionary, which may warrant closer attention from investors.